SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9,001.95 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 831,421.00 |
| Book Value / Share | 1,588.59 |
| Price / Book | n/a |
| NCAV ($M) | 262,376.00 |
| NCAV / Share | 501.32 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.06 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 2.71 |
| Current Ratio | 3.23 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 450,234.00 |
| Assets | 1,019,279.00 |
| Liabilities | 187,858.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 495,558.00 |
| Operating Income | 91,866.00 |
| Net Income | 59,870.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 67,884.00 |
| Cash from Investing | -142,387.00 |
| Cash from Financing | -84,697.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| KBYPF – Kobayashi Pharmaceutical Co., Ltd. | KLDO – Kaleido Biosciences, Inc. |
| KRBPQ – Kiromic BioPharma, Inc. | LABFF – Laboratorios Farmaceuticos Rovi, S.A. |
| LADX – LadRx Corporation |
Financial data and stock pages provided by
Fintel.io